How a 25-Cent Cancer Pill Became a Hundred-Billion-Dollar Business hosted by Jessica Lussenhop, with reporting by David Armstrong June 11, 2026, 6:15 am

How a 25-Cent Cancer Pill Became a Hundred-Billion-Dollar Business Reporter David Armstrong was diagnosed with cancer and soon learned that one of his drugs sold for almost $1,000 per pill — despite the fact it cost just pennies to make. What he found out helps explain why our healthcare system is the most expensive in the world. hosted by Jessica Lussenhop, with reporting by David Armstrong June 11, 2026, 6:15 am https://www.propublica.org/podcast/revlimid-cancer-drugs-fda-healthcare?utm_source=sailthru&utm_medium=email&utm_campaign=majorinvestigations&utm_content=secondary